1. Home
  2. SHCO vs VIR Comparison

SHCO vs VIR Comparison

Compare SHCO & VIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

SHCO

Soho House & Co Inc.

HOLD

Current Price

$8.96

Market Cap

1.7B

ML Signal

HOLD

Logo Vir Biotechnology Inc.

VIR

Vir Biotechnology Inc.

HOLD

Current Price

$5.75

Market Cap

773.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SHCO
VIR
Founded
1995
2016
Country
United Kingdom
United States
Employees
N/A
N/A
Industry
Hotels/Resorts
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
773.5M
IPO Year
2021
2019

Fundamental Metrics

Financial Performance
Metric
SHCO
VIR
Price
$8.96
$5.75
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
11
Target Price
$9.00
$25.73
AVG Volume (30 Days)
660.3K
2.0M
Earning Date
11-07-2025
11-05-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,288,973,000.00
$16,860,000.00
Revenue This Year
$11.89
N/A
Revenue Next Year
$7.87
$48.05
P/E Ratio
N/A
N/A
Revenue Growth
8.48
N/A
52 Week Low
$4.77
$4.16
52 Week High
$8.96
$14.45

Technical Indicators

Market Signals
Indicator
SHCO
VIR
Relative Strength Index (RSI) 68.41 42.12
Support Level $8.78 $6.49
Resistance Level $8.86 $6.75
Average True Range (ATR) 0.03 0.48
MACD 0.01 -0.09
Stochastic Oscillator 92.11 18.63

Price Performance

Historical Comparison
SHCO
VIR

About SHCO Soho House & Co Inc.

Soho House & Co Inc is a membership platform of physical and digital spaces that connects a vibrant, diverse group of members from across the world. The members use the platform to work, socialize, connect, create, and flourish all over the world. It offers lease agreements for Houses, hotels, restaurants, studios, spas, and other properties. The company's reportable segments are: United Kingdom; The Americas; and Europe and Rest of the world. The majority of its revenue is generated from the Americas segment, which encompasses its operating units in the Americas, including Soho Houses, stand-alone U.S. restaurants, Soho Friends, and the management fees under a hotel management contract for the operation of The Ned London.

About VIR Vir Biotechnology Inc.

Vir Biotechnology Inc is an immunology company focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions, including viral-associated diseases. Through internal development, collaborations, and acquisitions, it has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid, or siRNA. The company's pipeline consists of product candidates targeting hepatitis B, HBV, influenza A, human immunodeficiency virus, HIV, and tuberculosis, or TB. Its revenue sources are collaboration revenue, contract revenue, grant revenue, and license revenue.

Share on Social Networks: